Related Experiment Video
Updated: Jul 18, 2026
09:09
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
A simple, yet highly accurate, QSAR model captures the complement inhibitory activity of compstatin
Chandrika Mulakala1, John D Lambris, Yiannis Kaznessis
1Department of Chemical Engineering and Materials Science, and the Digital Technology Center, University of Minnesota, Minneapolis, MN 55455, USA.
Bioorganic & Medicinal Chemistry
|December 26, 2006
Summary
Compstatin analogs show significantly enhanced complement inhibition. A quantitative structure-activity relationship model identifies key molecular properties driving this improved activity for complement therapeutics.
Area of Science:
- Biochemistry
- Immunology
- Medicinal Chemistry
Background:
- Compstatin is a peptide inhibitor of complement activation.
- Recent development of compstatin analogs has yielded molecules with up to 260-fold increased activity.
- Understanding the structure-activity relationship is crucial for designing potent complement inhibitors.
Purpose of the Study:
- To develop a quantitative structure-activity relationship (QSAR) model for compstatin analogs.
- To identify key molecular features that enhance complement inhibitory activity.
- To provide insights for the rational design of novel complement inhibitors.
Main Methods:
- Generation of a dataset of compstatin analogs with varying activities.
- Development of a QSAR model using physico-chemical and geometrical parameters.
- Statistical analysis to determine significant correlations between molecular properties and activity (Radj2=0.89).
Main Results:
- A transparent four-parameter QSAR model was established.
- The number of aromatic bonds and hydrophobicity of the fourth residue strongly correlated with activity.
- Hydrophobic patch size near the disulfide bond and solvent-accessible surface area of basic residues were also significant predictors.
Conclusions:
- Physico-chemical and geometrical properties are critical determinants of compstatin analog activity.
- The developed QSAR model accurately predicts activity and highlights key design elements.
- This study facilitates the design of next-generation complement inhibitors with enhanced therapeutic potential.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...